Hansen Medical (NSDQ:HNSN) said today it inked an agreement with AB Medica Sagl to operate as the exclusive distributor of its Magellan robotic system in Switzerland.
The Magellan system drives Magellan robotic catheters and guide wires in minimally-invasive endovascular procedures and can be controlled remotely to allow for the use of interventional fluoroscopy during the procedures without risking radiation exposure, the company said.
“We are pleased to expand our relationship with AB Medica to include exclusive distribution of the Magellan Robotic System in Switzerland. This is another important step in the development of a strong global market for intravascular robotic systems. AB Medica is the largest medical technology distributor in Italy and Switzerland, and this expanded partnership will enable more patients to access and benefit from robotic endovascular procedures with Magellan,” Hansen CEO Cary Vance said in a press release.
AB Medica Sagl also serves as the company’s exclusive distributor in Italy, California-based Hansen Medical said. Hansen Medical shipped one of its Magellan robotic systems to AB Medica as part of the agreement, the company said.
Last month, Hansen Medical pulled the trigger on a reverse 10-for-1 stock split in which HNSN shareholders received 1 share for every 10 they owned.
The reverse split went into effect Sept. 22, according to a regulatory filing, sending HNSN shares down -13% to $4.35 apiece.
The post Hansen Medical inks distro deal with AB Medica Sagl appeared first on MassDevice.
from MassDevice http://ift.tt/1M4fkjT
Cap comentari:
Publica un comentari a l'entrada